161 related articles for article (PubMed ID: 29095301)
1. Lingual alveolar soft part sarcoma responsive to pazopanib: A case report.
Yoshihiro T; Tsuchihashi K; Nio K; Arita S; Nakano T; Yasumatsu R; Jiroumaru R; Ariyama H; Kusaba H; Oda Y; Akashi K; Baba E
Medicine (Baltimore); 2017 Nov; 96(44):e8470. PubMed ID: 29095301
[TBL] [Abstract][Full Text] [Related]
2. Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma.
Stacchiotti S; Mir O; Le Cesne A; Vincenzi B; Fedenko A; Maki RG; Somaiah N; Patel S; Brahmi M; Blay JY; Boye K; Sundby Hall K; Gelderblom H; Hindi N; Martin-Broto J; Kosela H; Rutkowski P; Italiano A; Duffaud F; Kobayashi E; Casali PG; Provenzano S; Kawai A
Oncologist; 2018 Jan; 23(1):62-70. PubMed ID: 28754721
[TBL] [Abstract][Full Text] [Related]
3. Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.
Mukaihara K; Tanabe Y; Kubota D; Akaike K; Hayashi T; Mogushi K; Hosoya M; Sato S; Kobayashi E; Okubo T; Kim Y; Kohsaka S; Saito T; Kaneko K; Suehara Y
PLoS One; 2017; 12(9):e0185321. PubMed ID: 28945796
[TBL] [Abstract][Full Text] [Related]
4. A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma.
Kim M; Kim TM; Keam B; Kim YJ; Paeng JC; Moon KC; Kim DW; Heo DS
Oncologist; 2019 Jan; 24(1):20-e29. PubMed ID: 30254189
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery as a primary treatment for metastatic skull base alveolar soft part sarcoma: a case report.
Shinya Y; Hasegawa H; Kawashima M; Shin M; Takahashi W; Kobayashi H; Saito N
Acta Neurochir (Wien); 2021 Feb; 163(2):351-355. PubMed ID: 32686069
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis, Prognosis, and Treatment of Alveolar Soft-Part Sarcoma: A Review.
Paoluzzi L; Maki RG
JAMA Oncol; 2019 Feb; 5(2):254-260. PubMed ID: 30347044
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma.
Conde N; Cruz O; Albert A; Mora J
Pediatr Blood Cancer; 2011 Dec; 57(6):1071-3. PubMed ID: 21744483
[TBL] [Abstract][Full Text] [Related]
8. Effective treatment of advanced alveolar soft part sarcoma with sunitinib: A case report.
Ye C; Wang J; Li W; Yuan M; Chai Y
Medicine (Baltimore); 2018 Dec; 97(51):e13584. PubMed ID: 30572461
[TBL] [Abstract][Full Text] [Related]
9. Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.
Judson I; Morden JP; Kilburn L; Leahy M; Benson C; Bhadri V; Campbell-Hewson Q; Cubedo R; Dangoor A; Fox L; Hennig I; Jarman K; Joubert W; Kernaghan S; López Pousa A; McNeil C; Seddon B; Snowdon C; Tattersall M; Toms C; Martinez Trufero J; Bliss JM
Lancet Oncol; 2019 Jul; 20(7):1023-1034. PubMed ID: 31160249
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas: A Japanese Musculoskeletal Oncology Group study.
Urakawa H; Kawai A; Goto T; Hiraga H; Ozaki T; Tsuchiya H; Nakayama R; Naka N; Matsumoto Y; Kobayashi E; Okuma T; Kunisada T; Ando M; Ueda T; Nishida Y
Cancer Sci; 2020 Sep; 111(9):3303-3312. PubMed ID: 32579783
[TBL] [Abstract][Full Text] [Related]
11. The Significant Effects of Pazopanib on Multiple Pulmonary Metastatic Lesions of Alveolar Soft Part Sarcoma: A Case Report.
Funakoshi Y; Okada M; Kawata S; Ito N; Abe K; Moriuchi H
J Pediatr Hematol Oncol; 2017 Apr; 39(3):238-239. PubMed ID: 28060129
[No Abstract] [Full Text] [Related]
12. Lingual Alveolar Soft Part Sarcoma in a 78-Year-Old Woman: A Case Report and Comprehensive Review of the Literature from 1952 to 2022.
Aksionau A; Dela Cruz NE; Meram AT; Cuellar-Saenz H; Aveni JR; Takei H
Head Neck Pathol; 2023 Mar; 17(1):265-274. PubMed ID: 36303014
[TBL] [Abstract][Full Text] [Related]
13. Lingual alveolar soft part sarcoma in a child managed successfully with surgery and chemotherapy.
Kumar M; Patne S; Vishwanath A; Hasan Z
Indian J Cancer; 2010; 47(2):234-5. PubMed ID: 20448401
[No Abstract] [Full Text] [Related]
14. Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group.
Malouf GG; Beinse G; Adam J; Mir O; Chamseddine AN; Terrier P; Honore C; Spano JP; Italiano A; Kurtz JE; Coindre JM; Blay JY; Le Cesne A
Oncologist; 2019 Jul; 24(7):980-988. PubMed ID: 30626710
[TBL] [Abstract][Full Text] [Related]
15. Alveolar soft-part sarcoma of the tongue in a 17-month-old.
Hillyer S; Vicens JC; Levinson H; Bhayani R; Mesea L; Chaudhry R; Fayans E; Fogler R
Ear Nose Throat J; 2009 Oct; 88(10):E4-9. PubMed ID: 19826991
[TBL] [Abstract][Full Text] [Related]
16. A retrospective analysis of 14 consecutive Chinese patients with unresectable or metastatic alveolar soft part sarcoma treated with sunitinib.
Li T; Wang L; Wang H; Zhang S; Atikan Kawuli ; Zhang X; Luo Z; Wang C
Invest New Drugs; 2016 Dec; 34(6):701-706. PubMed ID: 27604635
[TBL] [Abstract][Full Text] [Related]
17. Metastatic Alveolar Soft Part Sarcoma Responsive to Pazopanib after Progression through Sunitinib and Bevacizumab: Two Cases.
Read WL; Williams F
Case Rep Oncol; 2016; 9(3):639-643. PubMed ID: 27920695
[TBL] [Abstract][Full Text] [Related]
18. Cediranib phase-II study in children with metastatic alveolar soft-part sarcoma (ASPS).
Cohen JW; Widemann BC; Derdak J; Dombi E; Goodwin A; Dompierre J; Onukwubiri U; Steinberg SM; O'Sullivan Coyne G; Kummar S; Chen AP; Glod J
Pediatr Blood Cancer; 2019 Dec; 66(12):e27987. PubMed ID: 31502400
[TBL] [Abstract][Full Text] [Related]
19. Combined immunotherapy and targeted treatment for primary alveolar soft part sarcoma of the lung: case report and literature review.
Su H; Yu C; Ma X; Song Q
Invest New Drugs; 2021 Oct; 39(5):1411-1418. PubMed ID: 33765213
[TBL] [Abstract][Full Text] [Related]
20. Lingual alveolar soft part sarcoma with absent TFE3 rearrangement.
Alshahrani S; Khan A
Cancer Rep (Hoboken); 2021 Feb; 4(1):e1298. PubMed ID: 33026169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
